Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
Hong Kong’s 2025-26 Budget Advances Innovation and Technology
-
Dutch Bros® and Its Customers Raise More Than $1M for Local Organizations on Annual Dutch Luv Day
-
Tuya Smart x DeepSeek: The Revolutionary Path Empowered by Emotional Home Robots
-
Calumet Reports Fourth Quarter and Fiscal Year 2024 Results
-
WindSuite™ by Cv International: A Complete, Turn-Key Solution for Wind Turbine Nitrogen Servicing
-
Apellis Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Financial Results
-
Appian To Participate in Upcoming Investor Conferences
-
CoTec Holdings Corp. Announces Increase In Convertible Loan
-
Maywood Acquisition Corp. Announces Separate Trading of its Class A Ordinary Shares and Rights
-
Predictmedix AI Launches Advanced AI Health Stations to Target the US Market
-
Reaves Utility Income Fund Section 19(a) Notice
-
Clough Global Opportunities Fund Section 19(a) Notice
-
Clough Global Equity Fund Section 19(a) Notice
-
Clough Global Dividend and Income Fund Section 19(a) Notice
-
Canterra Minerals Selected for PDAC Core Shack
-
Cheems Memecoin Surpasses 80,000 Holders, Solidifying Its Place as a Leading Meme Token on BNB Chain
-
Anne De Greef-Safft joins Brady Corporation Board of Directors
-
HTX's USDD Earn Now Offers 20% APY: Hedge Against Crypto Crash with High Yield
-
Linvoseltamab Recommended for EU Approval by the CHMP to Treat Relapsed/Refractory Multiple Myeloma
-
Boralex reports net earnings of $74 million for fiscal 2024 and continues construction of its large-scale projects in Québec, Ontario and the United Kingdom
-
Opthea Reports Half Year Results and Business Updates
-
BioXcel Therapeutics Regains Compliance with Nasdaq Minimum Bid Price Rule
-
Golden Arrow Reports Initial Mineral Resource Estimate for San Pietro Copper-Gold-Iron-Cobalt Project, Chile
-
SKYLINEDX ANNOUNCES NEW PUBLICATION ON SKY92 GENE EXPRESSION PROFILING TEST in DEFINING ULTRA-HIGH-RISK MULTIPLE MYELOMA
-
CI Financial Reports Financial Results for the Fourth Quarter of 2024
-
Summit Midstream Corporation Announces Resumption of Preferred Dividend in First Quarter 2025
-
Cango Inc. to Report Fourth Quarter and Full Year 2024 Financial Results on March 6, 2025 Eastern Time
-
Fairfax Announces Intention to Redeem Cumulative Preferred Shares, Series E, F & M
-
GenBio AI Expands Global Leadership with Ziv Bar-Joseph as Co-Founder and Chief Scientific Officer
-
Bladex Achieves Record Financial Results and Increases Dividend by 25%
-
SINOVAC Announces New Board Pursuant to Privy Council Judgment and Order
-
Achilles Therapeutics Announces Voluntary Nasdaq Delisting and SEC Deregistration
-
Calumet Announces Sale of Assets Related to Industrial Portion of its Royal Purple® Business
-
Fulgent Reports Fourth Quarter and Full Year 2024 Financial Results
-
Abacus Announces Financing
-
Siyata Mobile Provides Additional Commentary Regarding the Terms of Its Proposed Merger with Core Gaming
-
Amerit Fleet Solutions Acquires Vector Fleet Management to Expand Service Offering and Broaden Fleet Management Capabilities
-
1stDibs Reports Fourth Quarter and Full Year 2024 Financial Results
-
Xali Gold Enters Option to Acquire Sarape Project Located Within Rio Sonora Valley, Mexico
-
OLD REPUBLIC DECLARES FIRST QUARTER REGULAR CASH DIVIDEND OF 29 CENTS PER SHARE
-
Sierra Space to Advance Cancer Research on Inaugural Dream Chaser® Spaceplane Mission to the International Space Station
-
Polestar Secures USD 450 Million Term Facility and Renews EUR 480 Million Green Trade Finance Facility
-
Enterprise 2024 Schedule K-1 Tax Packages Now Available
-
Akero Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update
-
LiveOne (Nasdaq: LVO) Surpasses 1 Million Subscribers, Including Tesla
-
TeraWulf Reports Fourth Quarter and Full Year 2024 Results
-
Plug Power Adopts Executive Compensation Program to Strengthen Leadership Alignment with Shareholders
-
NewGen Regains Compliance with Nasdaq Minimum Bid Price Requirement and Announces Listing Transfer to the Nasdaq Capital Market
-
ADMA Biologics to Participate in the Raymond James Institutional Investor Conference
-
Traws Pharma Regains Compliance with NASDAQ Equity Listing Rule

